Data as of 4:00pm ET
| -0.03 / -0.96%|
The 2 analysts offering 12-month price forecasts for Echo Therapeutics Inc have a median target of 6.50, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +111.04% increase from the last price of 3.08.
The current consensus among 2 polled investment analysts is to Outperform stock in Echo Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.